OpenAI CEO Sam Altman explains the IPO delay during a Fortune interview, citing safety risks.
OPENAI POSTPONES IPO AS SAFETY CRISIS INTENSIFIES
*Sam Altman tells Fortune the company will not go public this year, citing looming safety challenges. The delay reshapes the AI market, rattles investors, and sharpens regulatory scrutiny.*
Sam Altman announced to Fortune that OpenAI will not pursue an initial public offering this year. The decision arrives amid a cascade of safety incidents that have drawn fire from regulators in Washington and Brussels. Altman framed the postponement as a defensive move: going public now would expose investors to “material risk” from unresolved model‑bias and security flaws. The statement ripples through a market that has been betting on a rapid transition from private funding to Wall Street valuation. With a $29 billion valuation and a $5 billion cash cushion, OpenAI was poised to become the first AI unicorn to list, setting a price‑point for the entire sector. Instead, the company now faces a year‑long sprint to prove its safety architecture before the market will allow it to trade publicly.
Why the IPO Was Expected
Wall Street had priced OpenAI’s 2025 IPO at $30 billion, based on a $29 billion last‑round valuation and a $5 billion cash runway. Venture firms such as Andreessen Horowitz and Sequoia pledged $1.2 billion in pre‑IPO placements. Analysts projected a $120 billion market cap within three years, betting on ChatGPT’s 1.2 billion monthly active users. The prospect of a public float promised liquidity for early backers and a benchmark for the nascent generative‑AI sector.
Safety Concerns and Regulatory Heat
Altman’s reversal follows a spate of high‑profile mishaps: a disinformation bot that generated false election forecasts in June, a ransomware‑assisted breach of OpenAI’s API logs, and the EU’s AI Act moving toward enforcement in Q4. The U.S. Senate’s AI Oversight Committee scheduled a hearing for October, demanding audit trails for GPT‑5. Regulators warned that a public listing without robust safety protocols would trigger SEC “material risk” filings. Altman cited “an ill‑advised moment” to avoid exposing shareholders to potential liability and to buy time for a third‑party safety audit.
Strategic Implications for Competitors
Microsoft, holding a 49% equity stake, will now shoulder a larger share of OpenAI’s R&D spend—estimated at $2 billion annually. Anthropic’s $4 billion Series F round, led by Google’s parent Alphabet, gains a competitive edge as investors seek private‑market alternatives. Google DeepMind, under pressure from the UK’s AI safety regulator, accelerates its own safety‑by‑design roadmap. The IPO delay forces the entire sector to renegotiate valuation baselines, pushing private‑round multiples down from 30× to roughly 20× revenue.
What Delaying Means for the Market
Private investors now face a tighter funding environment. Global AI venture capital fell 12% YoY in Q3, with limited partners demanding tighter governance. OpenAI’s $5 billion cash reserve will stretch to early 2027, assuming a 30% burn rate. Analysts predict a “post‑IPO lull” that could depress secondary market pricing for AI tokens and related fintech products. The delay also gives regulators a window to draft clearer disclosure rules, potentially reshaping how AI firms report model risk to shareholders.
OpenAI’s delay signals that AI giants can no longer sidestep governance in the rush for capital. The company must now survive a year of heightened scrutiny, costly safety upgrades, and a cooling investor appetite. If it emerges with a vetted, compliant model, the eventual IPO could command a premium. If not, the market may turn its back, leaving the firm to fend for itself in a private‑equity arena that is rapidly tightening its leash.
Sources: CoinDesk, Fortune, SEC filings, EU AI Act documentation, Senate AI Oversight Committee schedule